Skip to main content
. 2018 Dec 6;4(4):2055217318815925. doi: 10.1177/2055217318815925

Figure 1.

Figure 1.

Kaplan-Meier curves for time to first relapse after the initiation of (a) azathioprine, (b) cellcept, and (c) rituximab, stratified by final diagnosis of seropositive neuromyelitis optica (NMO) versus limited seropositive neuromyelitis optica spectrum disorder (NMOSD).